The COVID-19 outbreak that is travelling across the world is revealing some unusual things in the clinical signs that seem to vary for every person and in distinct locations. Various organ systems might be affected differently in several amounts in different suffers. There has been several stories in the media as well as in the medical periodicals of a array of distinct skin disorders in people who have contracted coronavirus. Among the odd conditions that has been given some interest from the mass media is the way a lot of those with COVID-19 are developing chilblains, especially children and those who would not generally develop a chilblain. Chilblains are usually reasonably frequent at any rate in the colder environments. The earliest accounts of these chilblains in people that have COVID-19 was while in the wintertime in Spain as well as Italy, which means you may be expecting a number of people to get them in any case. Subsequent study focused on if they were just an incidental finding or if the infection was actually causing the chilblains and they're part of the pathophysiological process of the problem. This is still not clear at this time which one of these is the situation. These lesions have been given the name of COVID toes.
An instalment of the podiatry connected livestream, PodChatLive tackled this challenge on chilblains in COVID-19 and also the character of the phenomenon. The hosts of the livestream talked about the topic with Nadia Dembskey, a foot doctor from South Africa with a specific curiosity about this topic and who is thinking of pursing a PhD on the subject. In the episode, they did in particular cover the difficulties regarding if the chilblains really are a part of the disease process of the coronavirus or if they're just typical everyday chilblains which are merely more prevalent in those infected by COVID-19. This episode of PodChatLive ended up being broadcast live on Facebook and the edited version of the video is on YouTube, as well as an audio edition on the common podcast sites.